A plan to get generic versions of biotech drugs to market is close to winning approval from Congress. A bill likely to pass by Oct. 1 will give the Food and Drug Administration ...
The promise of cheaper biotechnology drugs has heightened the push for generic versions, but concerns about patient safety and hindering innovation have slowed the process.
The big health bill passed by a House committee late Friday has one provision that should please many big drug makers, and another that industry won't like.
Makers of generic drugs could apply to sell copies of medicines made by [bn:WBTKR=AMGN:US] Amgen Inc. [], [bn:WBTKR=DNA:US] Genentech Inc. [] and other biotech companies under ...
What do you call a drug that costs as much as $100,000 a year but doesn't face competition?If you're a consumer footing the bill, you might call it an unfair monopoly. If you're ...
WASHINGTON -- Senior members of Congress from both parties are working on legislation that could give consumers access to lower-cost copies of biotechnology drugs that now cost ...
Generic Biotech Drugs Index, featuring Generic Drugs news, Generic Drugs photos, Generic Drugs blogs, Generic Drugs articles, Generic Drugs videos, Generic Drugs shopping, Generic ...
Biotechnology drugs improve the quality of life for millions of Americans and make medical miracles happen every day - but can also be very expensive. So why aren't there generic ...
The Obama Administration wants to save money by streamlining approvals for "follow-on biologics." The biotech industry, with much to lose, cites risks.
The time may finally be ripe for a compromise as many big pharmaceutical companies move into biotech drugs.
